1. Torrent Pharmaceuticals
stock logo

67% Buy

Torrent Pharmaceuticals Share Price

TORNTPHARM

₹2,539.40-₹7.45 (-0.29%) Past YearLast updated on 19 Apr, 2024 | 03:59 PM IST
₹2,523.05₹2,560.00
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • F&O (Option chain)

  • More

Company overview

About

arrow

Market cap

Market Cap Switch₹86,197 Cr

Open

₹2,540.00

Close

₹2,546.85

Circuit range

₹2,801.50 - ₹2,292.20

Day range

₹2,523.05 - ₹2,560.00

Year range

₹1,580.00 - ₹2,744.00

Volume

2,87,483

Avg. traded

₹2,540.02

Revenue (12m)

₹10,474 Cr

Torrent PharmaceuticalsTorrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain, gynecology, and dermatology. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its acne/facecare products brands include Clinmiskin, ACNEMOIST, TRACNILO and fash. The Company's hair/scalp care products brands include Proanagen, Perlice, Permite and NOSKURF. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim. The Company's primary channel of distribution is through the wholesale drug distributors, stockiest and retail pharmacies.

Read more

Torrent Pharmaceuticals Key indicators

arrow

52 week high

₹2,744.00

52 week low

₹1,580.00

P/E ratio

57.31

P/B ratio

12.06

ROE

16.43%

ROCE

18.1%

Dividend yield

0.86%

Debt/Equity ratio

0.71

EPS

31.06

Learn more

Investment checklist: (3/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

67%

Hold

26%

Sell

7%

This analysis is based on the reviews of 27 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

32.47%

Net profit margin

13.4%

ROE

16.43%

ROA

8.75%

ROCE

18.1%

Learn more

Torrent Pharmaceuticals Shareholder returns

arrow

1 day

+0.36%

1 week

-1.21%

1 month

-0.89%

3 months

+3.42%

1 year

+59.71%

3 years

+94.45%

5 years

+177.34%

Revenue statement

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Cash flow

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Balance sheet

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Torrent Pharmaceuticals Share Price history

arrow
DayOpenCloseDay’s change
Thu, Apr 18 2024
₹2,555.00
₹2,546.85
-0.32%
Tue, Apr 16 2024
₹2,519.00
₹2,537.60
+0.73%
Mon, Apr 15 2024
₹2,530.50
₹2,519.85
-0.42%
Fri, Apr 12 2024
₹2,580.00
₹2,577.70
-0.09%
Wed, Apr 10 2024
₹2,579.95
₹2,578.95
-0.04%
Tue, Apr 9 2024
₹2,609.80
₹2,578.10
-1.23%
Mon, Apr 8 2024
₹2,595.05
₹2,597.30
+0.09%
Fri, Apr 5 2024
₹2,544.10
₹2,577.10
+1.28%

Shareholding info

arrow

Promoters (71.25%)

Mutual Funds (4.48%)

Retail and other (7.45%)

Foreign institutions-FII (14.08%)

Other domestic institutions (2.74%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹22/share

    Ex date 12 Feb 2024

    expand tab
  • Dividend • ₹8/share

    Ex date 23 Jun 2023

    expand tab
  • Dividend • ₹14/share

    Ex date 03 Feb 2023

    expand tab
  • Bonus • 1:1

    Ex date 08 Jul 2022

    expand tab
  • Dividend • ₹15/share

    Ex date 03 Jun 2022

    expand tab
  • Dividend • ₹8/share

    Ex date 03 Jun 2022

    expand tab
  • Dividend • ₹25/share

    Ex date 02 Feb 2022

    expand tab

Learn more

Frequently asked questions